Articles tagged "Outcome"

2016 American Transplant Congress
Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.
M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² M. Crespo,¹ J. Lloveras,¹ J. Tort,² J. Pascual,¹ Catalan Renal Registry Committee.²
¹Nephrology, Hospital del Mar, Barcelona, Spain; ²Catalan Renal Registry, Organització Catalana de Trasplantaments, Barcelona, Spain.
Large registries have shown that end-stage renal disease patients have longer survival after kidney transplantation (KT) than remaining on dialysis. However, the outcome for kidneys…
2016 American Transplant Congress
An Analysis of Non-Tuberculous Mycobacteria (NTM) Infection and Colonization in Lung Transplant Recipients (LTRs) Post-Transplant: A Single Center Matched Cohort Study.
H. Kozlowski,^1,2 D. Kabbani,³ C. Chaparro,^1,2 L. Singer,^1,2 C. Rotstein,^1,2 S. Keshavjee,^1,2 S. Husain.^1,2
¹University of Toronto, Toronto, ON, Canada; ²Toronto General Hospital, Toronto, ON, Canada; ³University of Alberta, Edmonton, AB, Canada.
PurposeNTM is a common infection after Lung transplantation. The role of presence of granuloma in the explanted lungs of LTRs in subsequent development of infection…
2016 American Transplant Congress
Controlled Cardiac Death Donor Program for Kidney Transplantation – Spanish Multicenter Experience with Two Years of Follow-Up.
J. Portoles,¹ M. Perez-Saez,² D. Hernandez-Marrero,² O. Lafuente,¹ F. Diekmann,² N. Maruri Kareaga,² M. Rodriguez-Ferrero,² F. Llamas,² M. Mazuecos,² J. Juega,² E. Melilli,² A. Rodriguez-Benot,² A. Alonso,² J. Pascual.²
¹Nephrology, U.H.Puerta de Hierro-RedinRen, Majadahonda, Spain; ²Nephrology, SENTRA-GEODAS Group, Madrid, Spain.
Background: Controlled donation after cardiac death (cDCD) programs are running in several countries for years. National transplant organization (ONT) has developed a nation-wide program in…
2016 American Transplant Congress
Early Hospital Readmisison Among Older Kideny Transplant Recipients.
E. King, L. Kucirka, M. McAdams-DeMarco, F. Al-Ammary, D. Segev.
Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.
BACKGROUND: We previously established 31% of all kidney transplant (KT) recipients experience early hospital readmission (EHR). We hypothesized that rates of EHR might be higher…
2016 American Transplant Congress
Thrombotic Microangiopathy After Kidney Transplantation: A Rare but Serious Complication.
C. Teixeira, I. Pietrobom, A. Lima, N. Tenório, G. Basso, M. Cristelli, L. Viana, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.
Universidade Federal de São Paulo, São Paulo, Brazil.
Purposes: Study the clinical characteristics of cases with thrombotic microangiopathy (TMA) in the renal allograft, identify the triggers of this disease and determine its impact…
2016 American Transplant Congress
The Effect of DRI and KDPI on Outcomes of High MELD Patients Undergoing Simultaneous Liver Kidney Transplant.
E. Chan,¹ M. Hertl,¹ J. Perkins.²
¹General Surgery, Rush University Medical Center, Chicago, IL; ²Surgery, University of Washington, Seattle, WA.
Background: Patients with a high Model for End Stage Liver Disease (MELD) score have an increased risk for dying without transplant. Renal function worsens secondary…
2016 American Transplant Congress
A Novel Murine Orthotopic Forelimb Transplantation Model That Allows for Reliable Assessment of Post-Transplant Upper Extremity Function.
J. Budihardjo,¹ B. Kern,^1,2 S. Mermulla,¹ A. Quan,¹ C. Cadmi,¹ J. Lopez,¹ J. Park,¹ A. Hoke,¹ W. Lee,¹ S. Tuffaha,¹ G. Brandacher.¹
¹Plastic Surgery, Johns Hopkins Medical Institutions, Baltimore, MD; ²Transplant Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Background: Studies related to functional return for upper extremity transplantation have been limited by the lack of a functional VCA animal model. The rat hindlimb…
2016 American Transplant Congress
Tailored Rabbit Anti-Thymocyte Globulin Induction (rATG) Dosing for Kidney Transplantation.
N. Singh,^1,2 A. Rossi,¹ M. Savic,¹ R. Rubocki,¹ M. Parker,¹ J. Vella.¹
¹MMC, Portland, ME; ²MGMC, Augusta, ME.
Purpose: Although rATG is the most commonly used induction immunotherapy for kidney transplantation (KT), optimal dosing remains unknown. In order to minimize adverse effects and…
2016 American Transplant Congress
Financial Cost of Cold Ischemia Time in Kidney Transplantation.
O. Serrano,¹ D. Vock,² W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas,¹ R. Feldman,³ E. Finger.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, University of Minnesota, Minneapolis, MN; ³Health Policy & Management, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: A new kidney allocation system (KAS) was implemented in December 2014 using the kidney donor profile index (KDPI), which prioritizes historically-disadvantaged populations. While KAS…
2016 American Transplant Congress
The Impact of Different Immunosuppressive Protocols on Early and Long Term Outcomes After Kidney and Pancreas Transplantation.
A. Rajab, R. Pelletier, A. El-Hinnawi, E. Elkhammas, G. Bumgardner, M. Henry.
Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH.
Between January 1990 and December 2014, 800 combined kidney pancreas transplant procedures were performed at The Ohio State University. The immunosuppressive protocols have changed significantly…